Loading company…
MedDay, founded in 2011 and based in Paris, France, is a biotechnology company focused on neuro-metabolic diseases.
MedDay is a biotechnology company focused on the treatment of neuro-metabolic diseases. Founded in 2011 and based in Paris, France, it is at the Series B stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in